Publications by Lise Sofie Haug Nissen-Meyer

50 publications found

1. Nguyen NT, Titze TL, Nissen-Meyer LSH (2024)
   Evaluation of transfusion reactions in patients following transfusion of blood components containing antibodies to HLA class I - An attempt to prevent TRALI in patients
   Transfus Apher Sci, 63 (4), 103970
   DOI 10.1016/j.transci.2024.103970, PubMed 38964256
2. Hetland G, Fagerhol MK, Mirlashari MR, Nissen-Meyer LSH, Croci S, Lonati PA, Bonacini M, Salvarani C, Marvisi C, Bodio C, Muratore F, Borghi MO, Meroni PL (2024)
   Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy
   Biomedicines, 12 (4)
   DOI 10.3390/biomedicines12040766, PubMed 38672123
3. Haugen M, Magnussen K, Aarsland TE, Nissen-Meyer LSH, Strand TA (2024)
   The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial
   Trials, 25 (1), 175
   DOI 10.1186/s13063-024-08035-7, PubMed 38468338
4. Mahmood F, Nissen-Meyer LSH, Hetland G, Nentwich I (2023)
   Assessing IgE sensitization profiles to birch and timothy grass pollen allergens in birch pollen allergic blood donors using an oligoplex specific IgE assay
   Scand J Clin Lab Invest, 83 (7), 444-447
   DOI 10.1080/00365513.2023.2255972, PubMed 37737679
5. Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
   DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
   Scand J Immunol, 98 (1), e13274
   DOI 10.1111/sji.13274, PubMed 37676118
6. Nissen-Meyer LSH, Steinsvåg TT, Fenstad MH, Sørvoll IH, Hvalryg M, Titze TL, Magnussen K, Kristoffersen G, Johnsen KMN, Llohn AH, Hermundstad B, Høiback LS, Haugen M, Kristoffersen EK, Boulland LML, Kran AB, Lund-Johansen F, Vaage JT, Flesland Ø, Hervig TA (2023)
   Convalescent plasma from Norwegian blood donors to treat COVID-19
   Tidsskr Nor Laegeforen, 143 (11)
   DOI 10.4045/tidsskr.22.0180, PubMed 37589362
7. Nissen-Meyer LSH, Macpherson ME, Skeie LG, Hvalryg M, Llohn AH, Steinsvåg TT, Fenstad MH, Tveita A, Kristoffersen EK, Sundic T, Lund-Johansen F, Vaage JT, Flesland Ø, Dyrhol-Riise AM, Holter JC, Hervig TA, Fevang B (2023)
   COVID-19 patients treated with convalescent plasma
   Tidsskr Nor Laegeforen, 143 (11)
   DOI 10.4045/tidsskr.22.0577, PubMed 37589359
8. Nissen-Meyer LSH (2023)
   Efforts to recruit and enhance blood donor return probability: A point of view from Oslo, Norway
   Transfus Apher Sci, 62 (4), 103760
   DOI 10.1016/j.transci.2023.103760, PubMed 37453908
9. Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Hetland G (2023)
   Effects of storage on quality and function of acid-treated platelets with reduced HLA Class I surface expression
   Transfus Med, 33 (4), 329-336
   DOI 10.1111/tme.12983, PubMed 37356816
10. Johnsen KMN, Magnussen K, Erstad C, Bhatti SN, Nissen-Meyer LSH (2023)
    Safe Blood Donation from Donors Using Antihypertensive Medication. A Multi-Center Retrospective Quality Study from South-East Norway
    J Blood Med, 14, 337-343
    DOI 10.2147/JBM.S390609, PubMed 37163174
11. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
    Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 8 (1), 4
    DOI 10.1038/s41541-023-00600-6, PubMed 36697432
12. Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J (2023)
    Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
    Cell Rep, 42 (1), 111995
    DOI 10.1016/j.celrep.2023.111995, PubMed 36656713
13. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
    Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 7 (1), 174
    DOI 10.1038/s41541-022-00586-7, PubMed 36585405
14. Hetland G, Fagerhol MK, Dimova-Svetoslavova VP, Mirlashari MR, Nguyen NT, Lind A, Kolset SO, Søraas AVL, Nissen-Meyer LSH (2022)
    Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors
    Scand J Clin Lab Invest, 82 (6), 481-485
    DOI 10.1080/00365513.2022.2123387, PubMed 36151851
15. Nissen-Meyer LSH, Czapp E, Naper C, Jensen T, Boulland LML (2022)
    Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination
    Transfus Apher Sci, 61 (5), 103567
    DOI 10.1016/j.transci.2022.103567, PubMed 36089469
16. Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
    Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
    Vaccines (Basel), 10 (8)
    DOI 10.3390/vaccines10081267, PubMed 36016155
17. Nissen-Meyer LSH, Ezligini F, Bergerud UE, Holtan A, Akkök ÇA, Danilova E, Hetland G (2022)
    [Blood and emergency preparedness]
    Tidsskr Nor Laegeforen, 142 (11)
    DOI 10.4045/tidsskr.22.0494, PubMed 35997179
18. Kared H, Wolf AS, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, Lund-Johansen F, Vaage JT, Nissen-Meyer LS, Nygaard UC, Hungnes O, Robertson AH, Næss LM, Trogstad L, Magnus P, Munthe LA, Mjaaland S (2022)
    Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
    Nat Commun, 13 (1), 4165
    DOI 10.1038/s41467-022-31888-y, PubMed 35851055
19. Hervig TA, Flesland Ø, Nissen-Meyer LSH (2022)
    COVID-19 convalescent plasma: current status, lessons from the past and future perspectives
    Transfus Apher Sci, 61 (4), 103487
    DOI 10.1016/j.transci.2022.103487, PubMed 35778352
20. Nissen-Meyer LSH, Hervig T, Fevang B, Norheim G, Kran AB, Vaage JT, Flesland Ø (2022)
    COVID-19 convalescent plasma from Norwegian blood donors
    Tidsskr Nor Laegeforen, 142 (9)
    DOI 10.4045/tidsskr.22.0057, PubMed 35699539
21. Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, Mjaaland S, Warren DJ, Kvien TK, Grødeland G, Nissen-Meyer LSH, Ricanek P, Chopra A, Andersson AM, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Lund-Johansen F, Jørgensen KK, Goll GL (2022)
    Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
    Arthritis Rheumatol, 74 (8), 1321-1332
    DOI 10.1002/art.42153, PubMed 35507355
22. Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
    Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
    Br J Haematol, 197 (6), 697-708
    DOI 10.1111/bjh.18149, PubMed 35254660
23. Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I et al. (2021)
    International Forum on Gender Identification and Blood Collection: Responses
    Vox Sang, 117 (3), E21-E43
    DOI 10.1111/vox.13193, PubMed 34545590
24. Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I et al. (2021)
    International Forum on Gender Identification and Blood Collection: Summary
    Vox Sang, 117 (3), 447-456
    DOI 10.1111/vox.13192, PubMed 34545579
25. Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Stensland ME, Singh SK, Nyman TA, Hetland G (2021)
    Proteomic study of apheresis platelets made HLA class I deficient for transfusion of refractory patients
    Proteomics Clin Appl, 15 (6), e2100022
    DOI 10.1002/prca.202100022, PubMed 34510746
26. Hvalryg M, Nissen-Meyer LSH (2021)
    Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021
    Transfus Apher Sci, 60 (5), 103256
    DOI 10.1016/j.transci.2021.103256, PubMed 34420881
27. Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
    Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
    Eur Heart J, 42 (39), 4064-4072
    DOI 10.1093/eurheartj/ehab506, PubMed 34405870
28. Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N et al. (2021)
    International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses
    Vox Sang, 116 (10), e71-e120
    DOI 10.1111/vox.13114, PubMed 34013981
29. Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N et al. (2021)
    International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary
    Vox Sang, 116 (10), 1117-1135
    DOI 10.1111/vox.13113, PubMed 34013968
30. Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H et al. (2021)
    International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses
    Vox Sang, 116 (3), e1-e24
    DOI 10.1111/vox.13038, PubMed 33754360
31. Nissen-Meyer LSH, Brantsæter AB (2021)
    The story of an extraordinary year: Challenges and opportunities in responding to Covid-19
    Transfus Apher Sci, 60 (2), 103092
    DOI 10.1016/j.transci.2021.103092, PubMed 33612447
32. Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Naper C, Tjønnfjord GE, Njerve IU, Ezligini F, Landmark BF, Meinke S, Sandgren P, Höglund P, Hetland G (2021)
    HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients
    Transfusion, 61 (4), 1222-1234
    DOI 10.1111/trf.16282, PubMed 33580979
33. Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LS, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinhar E, Gendelman V, Raz H et al. (2020)
    Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary
    Vox Sang, 116 (3), 351-359
    DOI 10.1111/vox.13037, PubMed 33245787
34. Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E (2020)
    Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies
    Nutrients, 12 (5)
    DOI 10.3390/nu12051339, PubMed 32397163
35. Fagerhol MK, Johnson E, Tangen JM, Hollan I, Mirlashari MR, Nissen-Meyer LSH, Hetland G (2020)
    NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study
    Scand J Immunol, 91 (5), e12870
    DOI 10.1111/sji.12870, PubMed 32034957
36. Mahmood F, Hetland G, Nentwich I, Mirlashari MR, Ghiasvand R, Nissen-Meyer LSH (2019)
    Agaricus blazei-Based Mushroom Extract Supplementation to Birch Allergic Blood Donors: A Randomized Clinical Trial
    Nutrients, 11 (10)
    DOI 10.3390/nu11102339, PubMed 31581605
37. Johnson E, Therkelsen SP, Nentwich I, Nissen-Meyer LSH, Hetland G (2019)
    IgE-sensitization to food and inhalant allergens in IBD patients compared with normal blood donors at Oslo University Hospital, Norway
    Scand J Gastroenterol, 54 (9), 1107-1110
    DOI 10.1080/00365521.2019.1663445, PubMed 31524013
38. Post JI, Leergaard TB, Ratz V, Walaas SI, von Hörsten S, Nissen-Meyer LSH (2019)
    Differential Levels and Phosphorylation of Type 1 Inositol 1,4,5-Trisphosphate Receptor in Four Different Murine Models of Huntington Disease
    J Huntingtons Dis, 8 (3), 271-289
    DOI 10.3233/JHD-180301, PubMed 31256144
39. Nissen-Meyer LSH, Seghatchian J (2018)
    Donor health assessment - When is blood donation safe?
    Transfus Apher Sci, 58 (1), 113-116
    DOI 10.1016/j.transci.2018.12.016, PubMed 30630765
40. Nissen-Meyer LSH, Chaudhry FA (2017)
    Corrigendum: Protein Kinase C Phosphorylates the System N Glutamine Transporter SN1 (Slc38a3) and Regulates Its Membrane Trafficking and Degradation
    Front Endocrinol (Lausanne), 8, 190
    DOI 10.3389/fendo.2017.00190, PubMed 28835749
41. Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA (2015)
    Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010
    Tidsskr Nor Laegeforen, 135 (11), 1039-43
    DOI 10.4045/tidsskr.14.0444, PubMed 26080779
42. Nissen-Meyer LS, Chaudhry FA (2013)
    Protein Kinase C Phosphorylates the System N Glutamine Transporter SN1 (Slc38a3) and Regulates Its Membrane Trafficking and Degradation
    Front Endocrinol (Lausanne), 4, 138
    DOI 10.3389/fendo.2013.00138, PubMed 24106489
43. Nissen-Meyer LS, Popescu MC, Hamdani el H, Chaudhry FA (2011)
    Protein kinase C-mediated phosphorylation of a single serine residue on the rat glial glutamine transporter SN1 governs its membrane trafficking
    J Neurosci, 31 (17), 6565-75
    DOI 10.1523/JNEUROSCI.3694-10.2011, PubMed 21525297
44. Pedersen ME, Fortunati D, Nielsen M, Brorson SH, Lekva T, Nissen-Meyer LS, Gautvik VT, Shahdadfar A, Gautvik KM, Jemtland R (2008)
    Calmodulin-dependent kinase 1beta is expressed in the epiphyseal growth plate and regulates proliferation of mouse calvarial osteoblasts in vitro
    Bone, 43 (4), 700-7
    DOI 10.1016/j.bone.2008.06.006, PubMed 18620088
45. Kvamme E, Nissen-Meyer LS, Roberg BA, Torgner IA (2008)
    Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria
    Neurochem Res, 33 (7), 1341-5
    DOI 10.1007/s11064-008-9589-9, PubMed 18274897
46. Nissen-Meyer LS, Svalheim S, Taubøll E, Gjerstad L, Reinholt FP, Jemtland R (2008)
    How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies
    Seizure, 17 (2), 187-91
    DOI 10.1016/j.seizure.2007.11.024, PubMed 18180177
47. Nissen-Meyer LS, Jemtland R, Gautvik VT, Pedersen ME, Paro R, Fortunati D, Pierroz DD, Stadelmann VA, Reppe S, Reinholt FP, Del Fattore A, Rucci N, Teti A, Ferrari S, Gautvik KM (2007)
    Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice
    J Cell Sci, 120 (Pt 16), 2785-95
    DOI 10.1242/jcs.003855, PubMed 17652162
48. Nissen-Meyer LS, Svalheim S, Taubøll E, Reppe S, Lekva T, Solberg LB, Melhus G, Reinholt FP, Gjerstad L, Jemtland R (2007)
    Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism
    Epilepsia, 48 (10), 1850-60
    DOI 10.1111/j.1528-1167.2007.01176.x, PubMed 17634065
49. Reppe S, Stilgren L, Abrahamsen B, Olstad OK, Cero F, Brixen K, Nissen-Meyer LS, Gautvik KM (2007)
    Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism
    Am J Physiol Endocrinol Metab, 292 (5), E1465-73
    DOI 10.1152/ajpendo.00487.2006, PubMed 17227961
50. Reppe S, Stilgren L, Olstad OK, Brixen K, Nissen-Meyer LS, Gautvik KM, Abrahamsen B (2006)
    Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism
    Bone, 39 (1), 189-98
    DOI 10.1016/j.bone.2005.12.020, PubMed 16516570